Mesterolone is a synthetic anabolic-androgenic steroid (AAS) and derivative of dihydrotestosterone (DHT). It is inactivated by 3?-hydroxysteroid dehydrogenase in skeleta muscules so it is considered a weak androgen. It is not a substrate for aromatase so it is not converted into estrogen. Mesterolone demonstrated to have minimal effect on sperm counts and levels of FSH or LH A27177, A27178. Experiments of mesterolone serving as a potential treatment of depression are still undergoing.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when Mesterolone is combined with Cyclosporine. |
| Dicoumarol | Mesterolone may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Mesterolone may increase the anticoagulant activities of Phenindione. |
| Warfarin | Mesterolone may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Mesterolone may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Mesterolone may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Mesterolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Mesterolone may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Mesterolone may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Mesterolone may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Mesterolone may increase the anticoagulant activities of Fluindione. |
| Clorindione | Mesterolone may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Mesterolone may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Mesterolone may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Mesterolone may increase the anticoagulant activities of (S)-Warfarin. |
| Insulin human | Mesterolone may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Mesterolone may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Mesterolone may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Mesterolone may increase the hypoglycemic activities of Insulin pork. |
| Troglitazone | Mesterolone may increase the hypoglycemic activities of Troglitazone. |
| Glimepiride | Mesterolone may increase the hypoglycemic activities of Glimepiride. |
| Sulfisoxazole | Mesterolone may increase the hypoglycemic activities of Sulfisoxazole. |
| Disopyramide | Mesterolone may increase the hypoglycemic activities of Disopyramide. |
| Acarbose | Mesterolone may increase the hypoglycemic activities of Acarbose. |
| Metformin | Mesterolone may increase the hypoglycemic activities of Metformin. |
| Sulfadiazine | Mesterolone may increase the hypoglycemic activities of Sulfadiazine. |
| Rosiglitazone | Mesterolone may increase the hypoglycemic activities of Rosiglitazone. |
| Acetohexamide | Mesterolone may increase the hypoglycemic activities of Acetohexamide. |
| Quinine | Mesterolone may increase the hypoglycemic activities of Quinine. |
| Miglitol | Mesterolone may increase the hypoglycemic activities of Miglitol. |
| Chlorpropamide | Mesterolone may increase the hypoglycemic activities of Chlorpropamide. |
| Nateglinide | Mesterolone may increase the hypoglycemic activities of Nateglinide. |
| Pentamidine | Mesterolone may increase the hypoglycemic activities of Pentamidine. |
| Mifepristone | Mesterolone may increase the hypoglycemic activities of Mifepristone. |
| Tolazamide | Mesterolone may increase the hypoglycemic activities of Tolazamide. |
| Repaglinide | Mesterolone may increase the hypoglycemic activities of Repaglinide. |
| Phenformin | Mesterolone may increase the hypoglycemic activities of Phenformin. |
| Sulfamethoxazole | Mesterolone may increase the hypoglycemic activities of Sulfamethoxazole. |
| Glyburide | Mesterolone may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Mesterolone may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Mesterolone may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Mesterolone may increase the hypoglycemic activities of Tolbutamide. |
| Pioglitazone | Mesterolone may increase the hypoglycemic activities of Pioglitazone. |
| Bromocriptine | Mesterolone may increase the hypoglycemic activities of Bromocriptine. |
| Gliquidone | Mesterolone may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | Mesterolone may increase the hypoglycemic activities of Mitiglinide. |
| Sitagliptin | Mesterolone may increase the hypoglycemic activities of Sitagliptin. |
| Sunitinib | Mesterolone may increase the hypoglycemic activities of Sunitinib. |
| Exenatide | Mesterolone may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Mesterolone may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Mesterolone may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | Mesterolone may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | Mesterolone may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Mesterolone may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Mesterolone may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Mesterolone may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Mesterolone may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Mesterolone may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Mesterolone may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Mesterolone may increase the hypoglycemic activities of Voglibose. |
| NN344 | Mesterolone may increase the hypoglycemic activities of NN344. |
| AMG-222 | Mesterolone may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Mesterolone may increase the hypoglycemic activities of Bisegliptin. |
| Alogliptin | Mesterolone may increase the hypoglycemic activities of Alogliptin. |
| Dapagliflozin | Mesterolone may increase the hypoglycemic activities of Dapagliflozin. |
| Saxagliptin | Mesterolone may increase the hypoglycemic activities of Saxagliptin. |
| Liraglutide | Mesterolone may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Mesterolone may increase the hypoglycemic activities of Gosogliptin. |
| Linagliptin | Mesterolone may increase the hypoglycemic activities of Linagliptin. |
| Canagliflozin | Mesterolone may increase the hypoglycemic activities of Canagliflozin. |
| Glibornuride | Mesterolone may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | Mesterolone may increase the hypoglycemic activities of Benfluorex. |
| Empagliflozin | Mesterolone may increase the hypoglycemic activities of Empagliflozin. |
| Albiglutide | Mesterolone may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Mesterolone may increase the hypoglycemic activities of Dulaglutide. |
| Lobeglitazone | Mesterolone may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | Mesterolone may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | Mesterolone may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | Mesterolone may increase the hypoglycemic activities of Ciglitazone. |
| Lixisenatide | Mesterolone may increase the hypoglycemic activities of Lixisenatide. |
| Insulin beef | Mesterolone may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Mesterolone may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Mesterolone may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Mesterolone may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Mesterolone may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Mesterolone may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Mesterolone may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Mesterolone may increase the hypoglycemic activities of Tofogliflozin. |
| Ertugliflozin | Mesterolone may increase the hypoglycemic activities of Ertugliflozin. |
| 2,4-thiazolidinedione | Mesterolone may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Mesterolone may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Mesterolone may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Mesterolone may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Mesterolone may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Mesterolone may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Mesterolone may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Mesterolone may increase the hypoglycemic activities of Sotagliflozin. |
| Balaglitazone | Mesterolone may increase the hypoglycemic activities of Balaglitazone. |
| Remogliflozin etabonate | Mesterolone may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | Mesterolone may increase the hypoglycemic activities of Carbutamide. |